右心室流出道直径对致心律失常性右心室心肌病事件的预测:超越超声心动图游离壁应变的增量价值
本研究在370例确诊致心律失常性右心室心肌病(ARVC)且具有基因检测结果的患者中,探讨超声心动图右心室流出道(RVOT)直径与室性心律失常(VA)或死亡的关系,并与100名健康对照比较诊断效能。结果显示RVOT扩张见于69%患者,孤立性扩张见于24%;各RVOT直径均有良好诊断效能(RVOT3/体表面积AUC 0.71),且与VA(HR 1.08)和死亡(HR 1.26)相关,其可行性、可重复性和结局关联均优于右心室游离壁应变。
要点
- RVOT扩张在ARVC患者中常见(69%),孤立性RVOT扩张占24%。
- 各RVOT直径诊断ARVC效能相似(RVOT3/体表面积AUC 0.71)。
- RVOT扩张与VA或死亡时间缩短相关,且优于右心室游离壁应变。
核心结论
- 孤立性RVOT扩张见于超过20%的ARVC患者;所有RVOT直径均显示良好诊断效能,与不良事件时间强烈相关,在一级和二级预防中均与不良事件相关,且可行性、可重复性和结局关联均优于右心室游离壁应变。
研究设计与样本
- 横断面结局研究,纳入370例确诊ARVC且有基因检测结果的患者(平均年龄47岁,56%男性,65%一级预防,中位随访6.8年),并与100名健康对照比较RVOT直径诊断效能。
关键影像表现/征象
- RVOT扩张发生于69%的患者,孤立性RVOT扩张(不伴右心室舒张末期面积扩张)发生于24%的患者。
- 所有RVOT直径的诊断效能相似(RVOT3/体表面积AUC 0.71,95%CI 0.66-0.76)。
- RVOT3/体表面积与VA相关(HR 1.08,95%CI 1.04-1.13;P<0.001),与死亡相关(HR 1.26,95%CI 1.18-1.35;P<0.001)。
- RVOT扩张与一级预防中VA或死亡时间缩短、二级预防中死亡时间缩短相关。
- RVOT直径的可行性更高、可重复性更好、结局关联更强,优于右心室游离壁应变。
诊断标准与关键数值
- RVOT扩张定义为RVOT直径增大;孤立性RVOT扩张定义为RVOT直径增大不伴右心室舒张末期面积扩张。
- RVOT3/体表面积诊断ARVC的AUC为0.71(95%CI 0.66-0.76)。
- RVOT3/体表面积与VA的HR为1.08(95%CI 1.04-1.13;P<0.001),与死亡的HR为1.26(95%CI 1.18-1.35;P<0.001)。
临床应用与阅片要点
- 在ARVC患者中应测量RVOT直径,其可行性和可重复性优于右心室游离壁应变。
- 孤立性RVOT扩张可见于24%的ARVC患者,阅片时需注意不伴右心室舒张末期面积扩张的情况。
- RVOT直径增大与室性心律失常或死亡风险增加相关,可用于一级和二级预防的风险评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Right ventricular outflow tract (RVOT) dilatation is a phenotypic feature of arrhythmogenic right ventricular cardiomyopathy (ARVC). The echocardiographic RVOT diameter is part of the 2010 Task Force Criteria and is widely measured in clinical practice. Nevertheless, few data exist on its prevalence, diagnostic value, and prognostic significance.
OBJECTIVES: This study aimed to explore the association of RVOT diameter with adverse outcomes in ARVC patients without (primary prevention) or with (secondary prevention) previous ventricular arrhythmia (VA), identify the best RVOT diameter for diagnosing ARVC, and understand whether isolated RVOT dilatation occurs in ARVC.
METHODS: Patients with definite ARVC and genetic testing results were included in a cross-sectional outcome study. Isolated RVOT dilatation was defined as an enlarged RVOT diameter without concurrent right ventricular (RV) end-diastolic area dilatation. The diagnostic power of RVOT diameter was assessed compared with 100 healthy control subjects. The time to first event after baseline echocardiography was analyzed by Cox regression.
RESULTS: The cohort consisted of 370 patients (mean age: 47 years; 56% male; 65% primary prevention; median follow-up: 6.8 years [Q1-Q3: 3.8-10.5 years]; 136 events [100 VA; 35 deaths]). RVOT dilatation occurred in 69% and isolated dilatation in 24% of patients. All RVOT diameters had similar diagnostic power (RVOT3/body surface area, AUC: 0.71 [95% CI: 0.66-0.76]) and a similar association with VA (RVOT3/body surface area, HR: 1.08 [95% CI: 1.04-1.13]; P < 0.001) or death (HR: 1.26 [95% CI: 1.18-1.35]; P < 0.001). Dilated RVOT was associated with a shorter time to VA or death in primary prevention and death in secondary prevention, and its feasibility was higher, its reproducibility was better, and its outcome association was stronger than those of RV free-wall strain.
CONCLUSIONS: Isolated RVOT dilatation occurred in >20% of ARVC patients. All RVOT diameters showed good diagnostic power, were strongly associated with time to adverse events, were associated with adverse events in primary and secondary prevention, and exhibited superior feasibility, reproducibility, and outcome association compared with RV free-wall strain.
引用
- Donati TG, Ortelli F, Hebeisen M, et al. Right Ventricular Outflow Tract Diameter for Event Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: Incremental Value Over Echocardiographic Free-Wall Strain. JACC Cardiovasc Imaging. 2025. PMID: 41342822. doi:10.1016/j.jcmg.2025.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。